Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria C Carrillo

Showing results (151-160 of 243) with videos related to

Pageof 25
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 24, 2025
Everyday functioning in young onset dementia: differences between diagnostic groupsEmma Weltings, Merel C Postema, Maureen van Dam, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 29, 2025
Alzheimer's Association Clinical Practice Guideline on the use of blood-based biomarkers in the diagnostic workup of suspected Alzheimer's disease within specialized care settingsSebastian Palmqvist, Heather E Whitson, Laura A Allen, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
Neuropsychiatric signs and symptoms of Alzheimer's disease: New treatment paradigmsKrista L Lanctôt, Joan Amatniek, Sonia Ancoli-Israel, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 24, 2012
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's diseaseBradley T Hyman, Creighton H Phelps, Thomas G Beach, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 2, 2013
Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task ForceBruno Vellas, Maria C Carrillo, Cristina Sampaio, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 27, 2026
Differences in amyloid PET positivity based on ethnoracial group and social determinants of health: The new IDEAS studyCorey J Bolton, Peggye Dilworth-Anderson, Jon Steingrimsson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 17, 2014
Vascular contributions to cognitive impairment and dementia including Alzheimer's diseaseHeather M Snyder, Roderick A Corriveau, Suzanne Craft, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 13, 2018
Military-related risk factors for dementiaHeather M Snyder, Roxana O Carare, Steven T DeKosky, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 25, 2025
Baseline characteristics of the U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (U.S. POINTER): Successful enrollment of a diverse clinical trial cohort at risk for cognitive declineRachel A Whitmer, Laura D Baker, Maria C Carrillo, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 30, 2018
Measuring cognition and function in the preclinical stage of Alzheimer's diseaseSandra Weintraub, Maria C Carrillo, Sarah Tomaszewski Farias, et al.
Pageof 25

Showing results (151-160 of 243) with videos related to

Sort By:
Pageof 25
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 24, 2025
Everyday functioning in young onset dementia: differences between diagnostic groupsEmma Weltings, Merel C Postema, Maureen van Dam, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 29, 2025
Alzheimer's Association Clinical Practice Guideline on the use of blood-based biomarkers in the diagnostic workup of suspected Alzheimer's disease within specialized care settingsSebastian Palmqvist, Heather E Whitson, Laura A Allen, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
Neuropsychiatric signs and symptoms of Alzheimer's disease: New treatment paradigmsKrista L Lanctôt, Joan Amatniek, Sonia Ancoli-Israel, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 24, 2012
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's diseaseBradley T Hyman, Creighton H Phelps, Thomas G Beach, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 2, 2013
Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task ForceBruno Vellas, Maria C Carrillo, Cristina Sampaio, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 27, 2026
Differences in amyloid PET positivity based on ethnoracial group and social determinants of health: The new IDEAS studyCorey J Bolton, Peggye Dilworth-Anderson, Jon Steingrimsson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 17, 2014
Vascular contributions to cognitive impairment and dementia including Alzheimer's diseaseHeather M Snyder, Roderick A Corriveau, Suzanne Craft, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 13, 2018
Military-related risk factors for dementiaHeather M Snyder, Roxana O Carare, Steven T DeKosky, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 25, 2025
Baseline characteristics of the U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (U.S. POINTER): Successful enrollment of a diverse clinical trial cohort at risk for cognitive declineRachel A Whitmer, Laura D Baker, Maria C Carrillo, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 30, 2018
Measuring cognition and function in the preclinical stage of Alzheimer's diseaseSandra Weintraub, Maria C Carrillo, Sarah Tomaszewski Farias, et al.
Pageof 25